Authors/Disclosures
|
|
No disclosure on file |
|
Sylvain Chouinard, MD
(CHUM-Notre-Dame)
|
No disclosure on file |
|
Nicolas Jodoin, MD
(CHUM)
|
No disclosure on file |
|
|
No disclosure on file |
|
Genevieve Bernard, MD
(Research Institute of the McGill University Health Centre)
|
Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Calico. Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Orchard Therapeutics. Dr. Bernard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for N/A. The institution of Dr. Bernard has received research support from Canadian Institutes of Health Research. The institution of Dr. Bernard has received research support from Montreal Children's Foundation. The institution of Dr. Bernard has received research support from Yaya Foundation for 4H Leukodystrophy. The institution of Dr. Bernard has received research support from Fondation Les Amis d'Elliot. The institution of Dr. Bernard has received research support from Ionis. Dr. Bernard has a non-compensated relationship as a Member of the Scientific Advisory Board with Pelizaeus-Merzbacher Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Chair of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Scientific and Clinical advisory Council with Yaya Foundation that is relevant to AAN interests or activities. |
|
|
No disclosure on file |
|
Nancy J. Newman, MD, FAAN
(Emory University School of Medicine)
|
Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. |
|
Michel Panisset, MD
|
No disclosure on file |